25 XP   0   0   10

Botanix Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse Botanix Pharmaceuticals Ltd together

PenkeI guess you are interested in Botanix Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Botanix Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Botanix Pharmaceuticals Ltd

I send you an email if I find something interesting about Botanix Pharmaceuticals Ltd.

Quick analysis of Botanix Pharmaceuticals Ltd (30 sec.)










What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.05
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$0.04
Return On Investment
18.6%

For what price can you sell your share?

Current Price per Share
A$0.22
Expected price per share
A$0.21 - A$0.24
How sure are you?
50%

1. Valuation of Botanix Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.22

Intrinsic Value Per Share

A$-0.11 - A$-0.06

Total Value Per Share

A$-0.09 - A$-0.05

2. Growth of Botanix Pharmaceuticals Ltd (5 min.)




Is Botanix Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$14.6m$5.2m$9.4m64.5%

How much money is Botanix Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$5.8m-$8.4m$2.5m43.9%
Net Profit Margin-1,000.5%-478.1%--

How much money comes from the company's main activities?

3. Financial Health of Botanix Pharmaceuticals Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd? (5 min.)

Welcome investor! Botanix Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Botanix Pharmaceuticals Ltd.

What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd?

First you should know what it really means to hold a share of Botanix Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Botanix Pharmaceuticals Ltd is A$0.22. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Botanix Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Botanix Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Botanix Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-1.7%0.00-1.7%-0.01-2.4%0.00-2.2%0.00-1.5%
Usd Book Value Change Per Share0.012.7%0.012.7%-0.01-2.3%0.000.2%0.000.5%
Usd Dividend Per Share0.000.2%0.000.2%0.013.8%0.002.1%0.001.0%
Usd Total Gains Per Share0.013.0%0.013.0%0.001.4%0.012.3%0.001.5%
Usd Price Per Share0.08-0.08-0.04-0.06-0.04-
Price to Earnings Ratio-22.37--22.37--6.82--17.46--17.84-
Price-to-Total Gains Ratio12.71-12.71-11.73--7.40-2.04-
Price to Book Ratio8.92-8.92-11.01-97.89-54.86-
Price-to-Total Gains Ratio12.71-12.71-11.73--7.40-2.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.140888
Number of shares7097
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.01
Gains per Quarter (7097 shares)46.5036.03
Gains per Year (7097 shares)186.00144.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11517117612915134
23034236225731278
34651254838646422
46168373451562566
57685492064477710
6911025110677292854
710611961292901108998
81221366147810301231142
91371537166411591381286
101521708185012871541430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%3.029.03.08.6%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%14.021.00.040.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%3.00.02.060.0%3.00.07.030.0%7.00.028.020.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%16.019.00.045.7%

Fundamentals of Botanix Pharmaceuticals Ltd

About Botanix Pharmaceuticals Ltd

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. Botanix Pharmaceuticals Limited was incorporated in 1984 and is based in Leederville, Australia.

Fundamental data was last updated by Penke on 2024-04-10 00:38:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Botanix Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Botanix Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -1,000.5% means that $-10.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -1,000.5%. The company is making a huge loss. -2
  • The TTM is -1,000.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,000.5%TTM-1,000.5%0.0%
TTM-1,000.5%YOY-478.1%-522.4%
TTM-1,000.5%5Y-2,100.0%+1,099.6%
5Y-2,100.0%10Y-2,784.2%+684.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,000.5%-197.2%-803.3%
TTM-1,000.5%-210.4%-790.1%
YOY-478.1%-279.3%-198.8%
5Y-2,100.0%-436.8%-1,663.2%
10Y-2,784.2%-599.3%-2,184.9%
1.1.2. Return on Assets

Shows how efficient Botanix Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -36.9% Return on Assets means that Botanix Pharmaceuticals Ltd generated $-0.37 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -36.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -36.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.9%TTM-36.9%0.0%
TTM-36.9%YOY-93.8%+57.0%
TTM-36.9%5Y-108.0%+71.1%
5Y-108.0%10Y-85.0%-23.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.9%-13.6%-23.3%
TTM-36.9%-12.9%-24.0%
YOY-93.8%-11.9%-81.9%
5Y-108.0%-14.2%-93.8%
10Y-85.0%-16.2%-68.8%
1.1.3. Return on Equity

Shows how efficient Botanix Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -39.9% Return on Equity means Botanix Pharmaceuticals Ltd generated $-0.40 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -39.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -39.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.9%TTM-39.9%0.0%
TTM-39.9%YOY-161.6%+121.7%
TTM-39.9%5Y-611.9%+572.1%
5Y-611.9%10Y-340.2%-271.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.9%-17.0%-22.9%
TTM-39.9%-16.1%-23.8%
YOY-161.6%-15.4%-146.2%
5Y-611.9%-20.0%-591.9%
10Y-340.2%-21.1%-319.1%

1.2. Operating Efficiency of Botanix Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Botanix Pharmaceuticals Ltd is operating .

  • Measures how much profit Botanix Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • An Operating Margin of -1,398.5% means the company generated $-13.98  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -1,398.5%. The company is operating very inefficient. -2
  • The TTM is -1,398.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,398.5%TTM-1,398.5%0.0%
TTM-1,398.5%YOY-578.7%-819.8%
TTM-1,398.5%5Y-2,237.5%+839.0%
5Y-2,237.5%10Y-2,616.7%+379.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,398.5%-286.1%-1,112.4%
TTM-1,398.5%-224.4%-1,174.1%
YOY-578.7%-288.4%-290.3%
5Y-2,237.5%-475.2%-1,762.3%
10Y-2,616.7%-624.7%-1,992.0%
1.2.2. Operating Ratio

Measures how efficient Botanix Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 14.98 means that the operating costs are $14.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 14.985. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.985. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.985TTM14.9850.000
TTM14.985YOY5.787+9.198
TTM14.9855Y44.198-29.213
5Y44.19810Y51.859-7.662
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.9852.997+11.988
TTM14.9853.247+11.738
YOY5.7873.766+2.021
5Y44.1985.675+38.523
10Y51.8597.857+44.002

1.3. Liquidity of Botanix Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.42 means the company has $7.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 7.416. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.416. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.416TTM7.4160.000
TTM7.416YOY1.784+5.632
TTM7.4165Y9.827-2.411
5Y9.82710Y10.394-0.567
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4163.930+3.486
TTM7.4164.251+3.165
YOY1.7845.436-3.652
5Y9.8276.045+3.782
10Y10.3946.363+4.031
1.3.2. Quick Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 5.70 means the company can pay off $5.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 5.697. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.697. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.697TTM5.6970.000
TTM5.697YOY1.262+4.436
TTM5.6975Y9.376-3.679
5Y9.37610Y10.156-0.780
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6973.629+2.068
TTM5.6974.065+1.632
YOY1.2625.397-4.135
5Y9.3765.993+3.383
10Y10.1566.277+3.879

1.4. Solvency of Botanix Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Botanix Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Botanix Pharmaceuticals Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Botanix Pharmaceuticals Ltd assets are financed with 7.6% credit (debt) and the remaining percentage (100% - 7.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 0.076. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.076. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.076TTM0.0760.000
TTM0.076YOY0.419-0.343
TTM0.0765Y0.299-0.223
5Y0.29910Y0.199+0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0760.332-0.256
TTM0.0760.334-0.258
YOY0.4190.268+0.151
5Y0.2990.366-0.067
10Y0.1990.390-0.191
1.4.2. Debt to Equity Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.2% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 0.082. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.082. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.082TTM0.0820.000
TTM0.082YOY0.722-0.640
TTM0.0825Y1.676-1.594
5Y1.67610Y0.893+0.783
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0820.381-0.299
TTM0.0820.390-0.308
YOY0.7220.334+0.388
5Y1.6760.434+1.242
10Y0.8930.466+0.427

2. Market Valuation of Botanix Pharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Botanix Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A PE ratio of -22.37 means the investor is paying $-22.37 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is -37.856. Based on the earnings, the company is expensive. -2
  • The MRQ is -22.369. Based on the earnings, the company is expensive. -2
  • The TTM is -22.369. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-37.856MRQ-22.369-15.486
MRQ-22.369TTM-22.3690.000
TTM-22.369YOY-6.817-15.552
TTM-22.3695Y-17.459-4.911
5Y-17.45910Y-17.839+0.380
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-37.856-2.315-35.541
MRQ-22.369-2.560-19.809
TTM-22.369-2.664-19.705
YOY-6.817-4.122-2.695
5Y-17.459-6.258-11.201
10Y-17.839-6.108-11.731
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is -18.117. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.705. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.705. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.117MRQ-10.705-7.411
MRQ-10.705TTM-10.7050.000
TTM-10.705YOY-6.365-4.340
TTM-10.7055Y-16.897+6.191
5Y-16.89710Y-580.273+563.376
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-18.117-3.067-15.050
MRQ-10.705-3.251-7.454
TTM-10.705-3.545-7.160
YOY-6.365-5.595-0.770
5Y-16.897-8.315-8.582
10Y-580.273-8.708-571.565
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Botanix Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.92 means the investor is paying $8.92 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is 15.099. Based on the equity, the company is expensive. -2
  • The MRQ is 8.922. Based on the equity, the company is overpriced. -1
  • The TTM is 8.922. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD15.099MRQ8.922+6.177
MRQ8.922TTM8.9220.000
TTM8.922YOY11.014-2.092
TTM8.9225Y97.890-88.968
5Y97.89010Y54.860+43.029
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD15.0991.905+13.194
MRQ8.9222.111+6.811
TTM8.9222.095+6.827
YOY11.0142.836+8.178
5Y97.8903.443+94.447
10Y54.8603.794+51.066
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Botanix Pharmaceuticals Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Botanix Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0090.0090%-0.008+185%0.001+1010%0.002+481%
Book Value Per Share--0.0150.0150%0.005+182%0.010+51%0.007+120%
Current Ratio--7.4167.4160%1.784+316%9.827-25%10.394-29%
Debt To Asset Ratio--0.0760.0760%0.419-82%0.299-75%0.199-62%
Debt To Equity Ratio--0.0820.0820%0.722-89%1.676-95%0.893-91%
Dividend Per Share--0.0010.0010%0.013-94%0.007-88%0.004-76%
Eps---0.006-0.0060%-0.008+44%-0.008+30%-0.005-14%
Free Cash Flow Per Share---0.012-0.0120%-0.009-26%-0.008-30%-0.005-56%
Free Cash Flow To Equity Per Share--0.0020.0020%-0.009+591%-0.001+150%0.001+164%
Gross Profit Margin--1.1461.1460%1.337-14%1.367-16%1.352-15%
Intrinsic Value_10Y_max---0.061--------
Intrinsic Value_10Y_min---0.106--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.009--------
Intrinsic Value_3Y_max---0.017--------
Intrinsic Value_3Y_min---0.029--------
Intrinsic Value_5Y_max---0.029--------
Intrinsic Value_5Y_min---0.050--------
Market Cap346530792.960+41%204768195.840204768195.8400%89782978.176+128%153103604.890+34%108684657.792+88%
Net Profit Margin---10.005-10.0050%-4.781-52%-21.000+110%-27.842+178%
Operating Margin---13.985-13.9850%-5.787-59%-22.375+60%-26.167+87%
Operating Ratio--14.98514.9850%5.787+159%44.198-66%51.859-71%
Pb Ratio15.099+41%8.9228.9220%11.014-19%97.890-91%54.860-84%
Pe Ratio-37.856-69%-22.369-22.3690%-6.817-70%-17.459-22%-17.839-20%
Price Per Share0.220+41%0.1300.1300%0.057+128%0.097+34%0.069+88%
Price To Free Cash Flow Ratio-18.117-69%-10.705-10.7050%-6.365-41%-16.897+58%-580.273+5320%
Price To Total Gains Ratio21.503+41%12.70712.7070%11.730+8%-7.401+158%2.036+524%
Quick Ratio--5.6975.6970%1.262+352%9.376-39%10.156-44%
Return On Assets---0.369-0.3690%-0.938+155%-1.080+193%-0.850+131%
Return On Equity---0.399-0.3990%-1.616+305%-6.119+1434%-3.402+753%
Total Gains Per Share--0.0100.0100%0.005+111%0.008+29%0.005+98%
Usd Book Value--14697837.69114697837.6910%5220397.991+182%9753920.489+51%6694103.762+120%
Usd Book Value Change Per Share--0.0060.0060%-0.005+185%0.001+1010%0.001+481%
Usd Book Value Per Share--0.0090.0090%0.003+182%0.006+51%0.004+120%
Usd Dividend Per Share--0.0010.0010%0.008-94%0.005-88%0.002-76%
Usd Eps---0.004-0.0040%-0.005+44%-0.005+30%-0.003-14%
Usd Free Cash Flow---12249433.514-12249433.5140%-9033434.370-26%-8557365.621-30%-5370555.140-56%
Usd Free Cash Flow Per Share---0.008-0.0080%-0.006-26%-0.005-30%-0.003-56%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.006+591%-0.001+150%0.000+164%
Usd Market Cap221918319.812+41%131133552.616131133552.6160%57497019.224+128%98047548.571+34%69601654.850+88%
Usd Price Per Share0.141+41%0.0830.0830%0.037+128%0.062+34%0.044+88%
Usd Profit---5862204.950-5862204.9500%-8434547.660+44%-7613055.860+30%-5064200.845-14%
Usd Revenue--585948.709585948.7090%1764196.334-67%2347152.070-75%1194245.585-51%
Usd Total Gains Per Share--0.0070.0070%0.003+111%0.005+29%0.003+98%
 EOD+6 -2MRQTTM+0 -0YOY+25 -115Y+25 -1110Y+22 -14

4.2. Fundamental Score

Let's check the fundamental score of Botanix Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-37.856
Price to Book Ratio (EOD)Between0-115.099
Net Profit Margin (MRQ)Greater than0-10.005
Operating Margin (MRQ)Greater than0-13.985
Quick Ratio (MRQ)Greater than15.697
Current Ratio (MRQ)Greater than17.416
Debt to Asset Ratio (MRQ)Less than10.076
Debt to Equity Ratio (MRQ)Less than10.082
Return on Equity (MRQ)Greater than0.15-0.399
Return on Assets (MRQ)Greater than0.05-0.369
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Botanix Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.126
Ma 20Greater thanMa 500.215
Ma 50Greater thanMa 1000.196
Ma 100Greater thanMa 2000.182
OpenGreater thanClose0.210
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets24,836
Total Liabilities1,885
Total Stockholder Equity22,951
 As reported
Total Liabilities 1,885
Total Stockholder Equity+ 22,951
Total Assets = 24,836

Assets

Total Assets24,836
Total Current Assets13,979
Long-term Assets10,857
Total Current Assets
Cash And Cash Equivalents 10,250
Net Receivables 489
Inventory 3,147
Other Current Assets 92
Total Current Assets  (as reported)13,979
Total Current Assets  (calculated)13,979
+/-0
Long-term Assets
Property Plant Equipment 65
Intangible Assets 10,729
Other Assets 3,937
Long-term Assets  (as reported)10,857
Long-term Assets  (calculated)14,732
+/- 3,874

Liabilities & Shareholders' Equity

Total Current Liabilities1,885
Long-term Liabilities0
Total Stockholder Equity22,951
Total Current Liabilities
Accounts payable 1,391
Other Current Liabilities 494
Total Current Liabilities  (as reported)1,885
Total Current Liabilities  (calculated)1,885
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock93,490
Retained Earnings -76,922
Accumulated Other Comprehensive Income 6,383
Total Stockholder Equity (as reported)22,951
Total Stockholder Equity (calculated)22,951
+/-0
Other
Capital Stock93,490
Cash and Short Term Investments 10,250
Common Stock Shares Outstanding 1,153,952
Liabilities and Stockholders Equity 24,836
Net Debt -10,250
Net Invested Capital 22,951
Net Tangible Assets 16,096
Net Working Capital 12,094
Property Plant and Equipment Gross 65



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
24,064
25,584
27,413
25,921
38,030
48,565
68,158
57,046
50,262
30,362
16,149
5,268
5,864
4,505
2,938
2,426
3,680
2,508
3,500
2,368
2,017
59
43
18
8
2,553
1,321
3,697
5,907
17,710
5,200
25,311
21,950
14,037
24,836
24,83614,03721,95025,3115,20017,7105,9073,6971,3212,55381843592,0172,3683,5002,5083,6802,4262,9384,5055,8645,26816,14930,36250,26257,04668,15848,56538,03025,92127,41325,58424,064
   > Total Current Assets 
9,575
10,976
13,616
14,631
21,568
28,161
41,982
26,328
28,854
17,437
8,840
5,268
5,864
3,034
923
2,245
1,707
525
1,522
396
50
52
40
18
8
2,553
1,321
3,697
5,907
17,710
5,188
24,777
21,610
10,501
13,979
13,97910,50121,61024,7775,18817,7105,9073,6971,3212,5538184052503961,5225251,7072,2459233,0345,8645,2688,84017,43728,85426,32841,98228,16121,56814,63113,61610,9769,575
       Cash And Cash Equivalents 
399
185
718
446
2,076
4,224
5,306
4,551
3,898
4,571
1,605
4,390
5,826
2,964
878
1,307
1,679
221
1,479
373
10
33
7
10
1
2,513
1,309
3,652
5,721
17,263
4,704
24,645
21,555
7,286
10,250
10,2507,28621,55524,6454,70417,2635,7213,6521,3092,513110733103731,4792211,6791,3078782,9645,8264,3901,6054,5713,8984,5515,3064,2242,076446718185399
       Short-term Investments 
0
0
0
1,395
1,269
1,751
2,044
3,661
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
0
0
0
00000200000000000000000000003,6612,0441,7511,2691,395000
       Net Receivables 
4,038
4,460
5,868
6,554
8,313
11,094
18,422
11,148
10,576
7,910
4,585
690
38
53
36
939
28
305
44
23
19
13
10
7
7
30
10
38
163
427
483
131
45
141
489
48914145131483427163381030771013192344305289393653386904,5857,91010,57611,14818,42211,0948,3136,5545,8684,4604,038
       Inventory 
5,108
6,285
7,014
6,225
9,904
11,086
16,197
6,949
10,377
3,844
2,644
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,044
3,044
3,147
3,1473,0443,0440000000000000000000002,6443,84410,3776,94916,19711,0869,9046,2257,0146,2855,108
       Other Current Assets 
30
46
16
11
6
6
13
19
4,003
1,112
6
188
0
17
9
0
0
0
0
0
21
6
23
0
0
11
2
7
24
20
0
1
10
30
92
9230101020247211002362100000917018861,1124,00319136611164630
   > Long-term Assets 
14,489
14,608
13,797
11,290
16,462
20,404
26,176
30,718
21,408
12,925
7,309
0
0
1,471
2,015
181
1,973
1,983
1,978
1,972
1,967
6
2
0
0
0
0
0
0
0
12
534
340
3,536
10,857
10,8573,536340534120000000261,9671,9721,9781,9831,9731812,0151,471007,30912,92521,40830,71826,17620,40416,46211,29013,79714,60814,489
       Property Plant Equipment 
8,081
7,471
9,217
8,351
12,430
14,930
19,714
19,790
14,650
12,768
7,118
0
0
186
113
181
12
26
21
16
10
6
2
0
0
0
0
0
0
0
12
445
278
179
65
65179278445120000000261016212612181113186007,11812,76814,65019,79019,71414,93012,4308,3519,2177,4718,081
       Goodwill 
1,585
1,501
1,419
0
0
0
0
0
0
0
0
0
0
0
0
0
1,961
1,957
1,957
1,957
1,957
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,9571,9571,9571,9571,96100000000000001,4191,5011,585
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
62
62
0
06262890000000000000000000000000000000
       Intangible Assets 
600
680
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,961
1,957
1,957
1,957
1,957
1,957
0
0
0
0
0
0
0
0
0
0
3,295
3,295
10,729
10,7293,2953,29500000000001,9571,9571,9571,9571,9571,96100000000000000680600
       Long-term Assets Other 
3,949
4,491
2,584
2,016
2,621
4,163
4,210
7,718
6,420
157
68
0
0
1,286
28
179
0
0
0
0
0
-1,957
0
0
0
0
0
0
0
0
-89
0
-278
-3,475
-6,921
-6,921-3,475-2780-8900000000-1,95700000179281,28600681576,4207,7184,2104,1632,6212,0162,5844,4913,949
> Total Liabilities 
11,819
13,623
14,538
14,515
19,684
22,521
29,718
19,133
18,216
14,610
8,065
118
169
458
289
182
223
284
603
1,082
1,139
1,855
2,274
2,352
2,509
310
92
516
471
1,426
4,585
1,674
1,150
5,886
1,885
1,8855,8861,1501,6744,5851,426471516923102,5092,3522,2741,8551,1391,0826032842231822894581691188,06514,61018,21619,13329,71822,52119,68414,51514,53813,62311,819
   > Total Current Liabilities 
9,293
10,832
11,697
11,431
15,821
18,245
25,066
12,778
17,256
13,963
7,508
118
169
443
275
182
222
284
603
1,082
1,139
971
886
2,352
2,509
310
92
516
471
1,426
4,585
1,378
1,038
5,886
1,885
1,8855,8861,0381,3784,5851,426471516923102,5092,3528869711,1391,0826032842221822754431691187,50813,96317,25612,77825,06618,24515,82111,43111,69710,8329,293
       Short-term Debt 
0
0
0
1,395
1,269
1,751
2,044
3,661
0
0
0
0
0
0
0
0
1
0
0
0
0
0
58
477
428
0
0
0
0
0
124
124
147
122
0
01221471241240000042847758000001000000003,6612,0441,7511,2691,395000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
118
0
0
62
0
194
94
275
148
332
137
134
259
205
280
33
456
454
911
4,485
1,177
652
4,682
1,391
1,3914,6826521,1774,48591145445633280205259134137332148275941940620011800000000000
       Other Current Liabilities 
7,430
9,177
9,271
7,253
9,705
10,360
10,203
2,991
8,549
5,318
2,252
0
0
343
213
0
27
190
328
933
807
835
695
1,615
1,876
30
33
60
17
515
100
77
239
1,081
494
4941,08123977100515176033301,8761,615695835807933328190270213343002,2525,3188,5492,99110,20310,3609,7057,2539,2719,1777,430
   > Long-term Liabilities 
2,526
2,791
2,841
3,084
3,863
4,276
4,652
6,355
960
647
557
0
0
15
15
0
1
0
0
0
0
884
1,388
0
0
0
0
0
0
0
296
296
112
5,790
0
05,79011229629600000001,3888840000101515005576479606,3554,6524,2763,8633,0842,8412,7912,526
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
296
112
0
0
001122960000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
15
15
0
0
0
0
0
0
884
1,388
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,38888400000015150000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,874
3,8740000000000000000000000000000000000
> Total Stockholder Equity
12,245
11,961
12,875
11,406
18,346
26,044
38,440
37,913
32,046
15,752
8,084
5,150
5,695
4,047
2,649
2,245
3,430
2,224
2,897
1,286
878
-1,797
-2,231
-2,334
-2,501
2,244
1,229
3,181
5,437
16,285
615
23,637
20,800
8,152
22,951
22,9518,15220,80023,63761516,2855,4373,1811,2292,244-2,501-2,334-2,231-1,7978781,2862,8972,2243,4302,2452,6494,0475,6955,1508,08415,75232,04637,91338,44026,04418,34611,40612,87511,96112,245
   Common Stock
8,266
8,266
8,266
8,841
9,013
12,513
19,623
19,625
22,512
22,512
35,926
36,601
37,499
37,261
37,261
37,816
68,766
7,475
12,233
13,447
15,970
17,194
18,228
19,704
21,372
25,658
25,658
4,717
11,632
33,299
33,890
71,414
71,476
71,476
93,490
93,49071,47671,47671,41433,89033,29911,6324,71725,65825,65821,37219,70418,22817,19415,97013,44712,2337,47568,76637,81637,26137,26137,49936,60135,92622,51222,51219,62519,62312,5139,0138,8418,2668,2668,266
   Retained Earnings 
625
326
1,226
-540
1,153
3,621
7,303
8,799
-3,875
-20,945
-28,153
-31,325
-31,804
-33,214
-34,613
-35,571
-65,336
-6,360
-9,777
-12,602
-15,646
-19,591
-21,111
-22,214
-24,064
-25,195
-26,209
-1,708
-6,481
-17,493
-34,532
-51,263
-54,597
-67,768
-76,922
-76,922-67,768-54,597-51,263-34,532-17,493-6,481-1,708-26,209-25,195-24,064-22,214-21,111-19,591-15,646-12,602-9,777-6,360-65,336-35,571-34,613-33,214-31,804-31,325-28,153-20,945-3,8758,7997,3033,6211,153-5401,226326625
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
3,354
3,369
3,383
9,642
16,708
21,009
25,794
27,010
35,723
39,420
26,331
0
0
37
0
0
0
0
0
0
0
0
0
0
0
0
0
6
286
479
1,258
-20,151
-16,879
-3,708
-16,568
-16,568-3,708-16,879-20,1511,25847928660000000000000370026,33139,42035,72327,01025,79421,00916,7089,6423,3833,3693,354



Balance Sheet

Currency in AUD. All numbers in thousands.